Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE

Autor: San-Miguel, J. Avet-Loiseau, H. Paiva, B. Kumar, S. Dimopoulos, M.A. Facon, T. Mateos, M.-V. Touzeau, C. Jakubowiak, A. Usmani, S.Z. Cook, G. Cavo, M. Quach, H. Ukropec, J. Ramaswami, P. Pei, H. Qi, M. Sun, S. Wang, J. Krevvata, M. DeAngelis, N. Heuck, C. Van Rampelbergh, R. Kudva, A. Kobos, R. Qi, M. Bahlis, N.J.

In patients with transplant-ineligible newly diagnosed multiple myeloma (NDMM), daratumumab reduced the risk of disease progression or death by 44% in MAIA (daratumumab/lenalidomide/dexamethasone [D-Rd]) and 58% in ALCYONE (daratumumab/bortezomib/mel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::9171ad68441f80d41018dc420b6da8d2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2999635

Establishment and characterization of 18 Sarcoma Cell Lines: Unraveling the Molecular Mechanisms of Doxorubicin Resistance in Sarcoma Cell Lines.

Autor: Cho, Young-Eun^1,2 (AUTHOR), Kim, Soon-Chan^1,3 (AUTHOR), Kim, Ha Jeong⁴ (AUTHOR), Han, Ilkyu⁴ (AUTHOR) hik19@snu.ac.kr, Ku, Ja-Lok^1,2,3,5 (AUTHOR) kujalok@snu.ac.kr

Publikováno v: Journal of Translational Medicine. 10/2/2024, Vol. 22 Issue 1, p1-14. 14p.

Mycotic Aneurysm of the Popliteal Artery Secondary to Enterococcus Endo-carditis : a Case Report

Autor: S K, Yogeswaran, P, Stabel, J, Avet, G, Daenen

Publikováno v: Acta chirurgica Belgica. 114(6)

A mycotic popliteal aneurysm (MAAP) is a very rare condition [1]. We describe a 87-year-old Caucasian male who presented with a MAAP of the right leg due to an enterococcus mitral valve endocarditis. The aneurysm was excised and a reversed vein graft

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::993dd8c06a326ce5a2bff117fac11308
https://pubmed.ncbi.nlm.nih.gov/26021690

Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.

Autor: Zabaleta A; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain., Cedena MT; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain., Oliver-Caldes A; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Perez JJ; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain., Moreno C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Tamariz-Amador LE; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Rodriguez-Otero P; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Prosper F; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Gonzalez-Calle V; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain., López-Corral L; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain., Rey-Búa B; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain., Puertas B; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain., Mirás F; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain., Sánchez-Pina JM; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain., López-Muñoz N; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain., Juan M; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., González-Navarro EA; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Urbano Á; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., de Larrea CF; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Blade J; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Lahuerta JJ; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain., Martinez-Lopez J; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain., Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain., San Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Paiva B; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Nov 16. Date of Electronic Publication: 2024 Nov 16.

Towards IVDR‐compliance by implementing quality control steps in a quantitative extracellular vesicle‐miRNA liquid biopsy assay for response monitoring in patients with classic Hodgkin lymphoma.

Autor: Drees, Esther E. E.^1,2 (AUTHOR), Groenewegen, Nils J.^1,2,3 (AUTHOR), Verkuijlen, Sandra A. W. M.^1,2 (AUTHOR), van Eijndhoven, Monique A. J.^1,2 (AUTHOR), Ramaker, Jip^1,2 (AUTHOR), Veenstra, Pepijn^1,2 (AUTHOR), Hussain, Mirjam^1,2 (AUTHOR), Groothuis‐Oudshoorn, Catharina G. M.⁴ (AUTHOR), de Jong, Daphne^1,2 (AUTHOR), Zijlstra, Josée M.^2,5 (AUTHOR), de Rooij, Johan³ (AUTHOR), Pegtel, D. Michiel^1,2,3 (AUTHOR) d.pegtel@amsterdamumc.nl

Publikováno v: Journal of Extracellular Biology. Jul2024, Vol. 3 Issue 7, p1-12. 12p.